Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 CAD | -1.45% | +1.49% | -12.82% |
Apr. 25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call |
Sales 2024 * | 18.59M 25.44M | Sales 2025 * | 21.32M 29.17M | Capitalization | 33.95M 46.46M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.83 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
17
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.65% |
Latest transcript on Microbix Biosystems Inc.
1 day | -1.45% | ||
1 week | +1.49% | ||
Current month | -1.45% | ||
1 month | -8.11% | ||
3 months | -12.82% | ||
6 months | +36.00% | ||
Current year | -12.82% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
James Currie
DFI | Director of Finance/CFO | - | 16-10-31 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 90-09-30 |
Peter Blecher
BRD | Director/Board Member | - | 05-12-05 |
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.34 | -1.45% | 1,500 |
24-04-30 | 0.345 | +4.55% | 53,786 |
24-04-29 | 0.33 | +1.54% | 194,209 |
24-04-26 | 0.325 | -2.99% | 166,766 |
24-04-25 | 0.335 | 0.00% | 2,500 |
Delayed Quote Toronto S.E., May 01, 2024 at 10:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 34.09M | |
+24.77% | 48.09B | |
+47.30% | 40.62B | |
-2.92% | 40.43B | |
-6.20% | 28.36B | |
+7.52% | 24.89B | |
-19.18% | 19.01B | |
+29.32% | 12.09B | |
-0.76% | 11.88B | |
-0.88% | 11.8B |
- Stock Market
- Equities
- MBX Stock